AzTrials
AzTrials

ICU-acquired WeaknessNCT07896057

Evidence-based, Customized, Motion-recognition Rehabilitation System Development for Bed-ridden Patients - Validation of Effectiveness: Rehabit: Swim

A study testing Rehabilitation in people with ICU-acquired Weakness, run by Asan Medical Center at 1 site in South Korea.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This pilot study aims to evaluate the efficacy, safety, feasibility, and user satisfaction of "Rehabit: swim," a customized, evidence-based, motion-recognition-based rehabilitation exergame designed for hospitalized patients with limited mobility, particularly those with a history of intensive care unit (ICU)… Read more about this study

Who is it for?
Ages 18 to 79 years
Conditions the study is for
ICU-acquired Weakness
What is being tested?
Rehabilitation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteSouth Korea
Study dates
1 Nov 2026to 30 Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 79 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 19 years or older
  • Patients who have a history of intensive care unit (ICU) admission during their hospital stay

Who cannot join

  • Patients who have difficulty cooperating with the rehabilitation exercise program due to inappropriate conscious level or cognitive level
  • Patients with persistent biomechanical instability
  • Patients requiring movement restrictions due to fractures or skeletal instability that limit the necessary movements for the rehabilitation exercise program

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Won Kim, ph.D. contact

82+2-3010-1694

duocl79@gmail.com

South Korea1 site
  • Asan Medical Center

    Seoul

Other trials in South Korea

About this study

This pilot study aims to evaluate the efficacy, safety, feasibility, and user satisfaction of "Rehabit: swim," a customized, evidence-based, motion-recognition-based rehabilitation exergame designed for hospitalized patients with limited mobility, particularly those with a history of intensive care unit (ICU) admission. A total of 20 participants will perform the rehabilitation exergaming program while lying or sitting in bed. The intervention consists of 30-minute sessions, once a day, for a total of 10 sessions over approximately 2 weeks. Clinical outcomes, physical performance measures, and user experience metrics will be assessed before and after the intervention.

Read the detailed description

Background \& Rationale: Hospitalized patients, especially those recovering from critical illnesses or experiencing ICU-acquired weakness (ICU-AW) and sarcopenia, often face severe mobility restrictions. While early rehabilitation is crucial for functional recovery and reducing complications, available exercise options for bedridden patients are frequently monotonous, limiting patient motivation and adherence. To overcome these limitations, "Rehabit: swim," a customized interactive exergame optimized for bedridden patients, was developed.

Study Objectives: The primary objective is to investigate the efficacy, safety, and feasibility of utilizing the Rehabit: swim exergaming program in improving physical function, muscle strength, mobility, and quality of life among hospitalized patients with a history of ICU stays.

Study Design \& Methods:

Design: A prospective, single-center pilot study. Participants: 20 adult inpatients (≥19 years old) who meet the inclusion and exclusion criteria, including a history of ICU admission during their hospital stay.

Intervention: Participants will perform tailored rehabilitation exercise games using Rehabit: swim while in a bed (lying or sitting posture). The intervention is planned for 30 minutes per session, once daily, 10 sessions total within a 2-week period (extendable up to 3 weeks depending on condition).

Outcomes and Data Collection:

Clinical \& Functional Assessments: Evaluated at pre- and post-intervention, including Medical Research Council Sum Score (MRC-SS), grip strength, Functional Ambulatory Category (FAC), ICU Mobility Scale (ICU-MS), EQ-5D, EQ-VAS, K-MMSE2, Intrinsic Motivation Inventory (IMI), and Game User Experience Satisfaction Scale-18 (GUESS-18).

Intervention Metrics: Physical motion data (range of motion, angles, speed) captured via Inertial Measurement Units (IMUs), built-in metrics (calories burned, game scores, exercise time), heart rate changes, adherence, session completion/cessation reasons, and adverse events (e.g., falls).

Being tested
Rehabilitation
Keywords
Exergaming, Virtual Reality Rehabilitation, Motion Recognition, Bedridden Patients, Rehabilitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RehabilitationDevice

    Hospitalized patients with limited mobility, including those with a history of intensive care unit (ICU) admission, will perform customized rehabilitation exercise games using the "Rehabit: swim" motion-recognition system in a bed setting. The intervention is administered for 30 minutes per session, once daily, totaling 10 sessions over approximately 2 weeks.

Study groups in NCT07896057
Study groupRoleWhat they receive
InterventionalExperimentalAll participants will receive the Rehabit: swim rehabilitation exergaming intervention for approximately 2 weeks (total of 10 sessions, 30 minutes per session) while in a bed (lying or sitting posture).
Receives: Device: Rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Session Adherence Rate

    Percentage of the 10 planned Rehabit: swim sessions attended by each participant, calculated as (number of sessions attended ÷ 10) × 100. A session is counted as attended when the participant starts the scheduled exercise-game session.

    Measured: From the first intervention session (Game 1) through the tenth session (Game 10), up to 3 weeks

  2. Intervention Completion Rate

    Percentage of enrolled participants who complete all 10 Rehabit: swim sessions within 3 weeks of the first session.

    Measured: From the first intervention session (Game 1) through the tenth session (Game 10), up to 3 weeks

Secondary outcomes (8)
  1. Medical Research Council Sum Score (MRC-SS)

    Change in muscle strength assessed using the MRC-SS. Scores range from 0 to 60; higher scores indicate greater muscle strength (better outcome).

    Measured: Baseline and post-intervention (approx. 2 weeks).

  2. Grip Strength

    Change in handgrip strength.

    Measured: Baseline and post-intervention (approx. 2 weeks).

  3. Functional Ambulatory Category (FAC)

    Changes in functional mobility and ambulation status measured by the Functional Ambulation Category (FAC). Scores range from 0 (nonfunctional ambulator) to 5 (independent ambulator on any surface, including stairs); higher scores indicate greater walking independence (better outcome).

    Measured: Baseline and post-intervention (approx. 2 weeks).

  4. ICU Mobility Scale (ICU-MS)

    Changes in functional mobility and ambulation status measured by the Intensive Care Unit Mobility Scale (ICU-MS). Scores range from 0 (lying in bed, no active movement) to 10 (walking independently without a gait aid); higher scores indicate greater mobility (better outcome).

    Measured: Baseline and post-intervention (approx. 2 weeks).

  5. EQ-5D-5L Index

    Health-related quality of life measured with the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L), which assesses mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each rated on 5 levels from no problems to extreme problems. Responses are converted to a single index value using the Korean EQ-5D-5L value set (range -0.066 to 1; higher values indicate better health). Change is calculated as the post-intervention value minus the baseline value; positive values indicate improvement.

    Measured: Baseline and post-intervention (approx. 2 weeks).

  6. EQ-VAS

    Self-rated overall health measured with the EQ-VAS, ranging from 0 (worst imaginable health) to 100 (best imaginable health); higher scores indicate better self-rated health. Change is calculated as the post-intervention score minus the baseline score; positive values indicate improvement.

    Measured: Baseline and post-intervention (approx. 2 weeks).

  7. Intrinsic Motivation Inventory (IMI) Interest/Enjoyment Subscale Score

    Intrinsic motivation toward the Rehabit: swim exercise game measured with the Interest/Enjoyment subscale of the IMI, consisting of 7 items rated from 1 ("not at all true") to 7 ("very true"), with 2 items reverse-scored. The subscale score is the mean of the 7 items (range 1 to 7); higher scores indicate greater intrinsic motivation.

    Measured: Baseline and post-intervention (approx. 2 weeks).

  8. Game User Experience Satisfaction Scale-18 (GUESS-18) Composite Score

    Satisfaction with the Rehabit: swim exercise game measured with the GUESS-18, consisting of 18 items across 9 subscales rated from 1 ("strongly disagree") to 7 ("strongly agree"), with 1 item reverse-scored. Items are averaged within each subscale, and the 9 subscale scores are summed to obtain the composite score (range 9 to 63); higher scores indicate greater game satisfaction.

    Measured: Baseline and post-intervention (approx. 2 weeks).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2026
  2. Study start1 Nov 2026 (estimated)
  3. Primary completion30 Sep 2027 (estimated)
  4. Study completion30 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07896057
Sponsor's protocol ID
S2026-2528-0001
Status last verified
Oct 2026
First submitted
8 Oct 2026
Last updated
26 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Rehabilitation in people with ICU-acquired Weakness, run by Asan Medical Center at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Won Kim, ph.D. (82+2-3010-1694, duocl79@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Session Adherence Rate (time frame: From the first intervention session (Game 1) through the tenth session (Game 10), up to 3 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in